Literature DB >> 23910226

Haemoglobin, neutrophil to lymphocyte ratio and platelet count improve prognosis prediction of the TNM staging system in nasopharyngeal carcinoma: development and validation in 3,237 patients from a single institution.

H Chang1, J Gao, B Q Xu, S P Guo, R B Lu, G Li, S M Huang, F Han, Z G Liu, Y L Tao, Z W Tu, C Chen, X H Li, Y F Xia.   

Abstract

AIMS: To improve prediction efficiency by incorporating complete blood count (CBC) into the TNM system on 5 year disease-specific survival (DSS) for patients with nasopharyngeal carcinoma (NPC).
MATERIALS AND METHODS: The CBC of 3237 patients undergoing radiotherapy was retrospectively evaluated. In total, 2820 patients treated with non-intensity-modulated radiotherapy (IMRT) were randomly divided into development (1895 patients) and validation cohorts (925 patients). The association of potential risk factors with 5 year DSS was tested by Cox proportional hazards analysis and a prognostic index was created by assigning weighted scores proportional to a regression coefficient to each factor. Each cohort was divided into low, intermediate and high prognostic index. The prognostic index was validated in the validation cohort and compared with the TNM system on prediction of 5 year DSS. Validation was repeated in another independent group of 417 patients treated with IMRT.
RESULTS: Eight independent prognostic factors were identified: gender, age, T or N stages, anaemia or thrombocytosis during radiotherapy, continuous reduction in haemoglobin, high neutrophil-lymphocyte ratio before radiotherapy. Each was assigned a number of points. The area under curve (AUC) of the prognostic index was larger than that of Union Internationale Contre le Cancer/American Joint Cancer Committee TNM system 2009 (0.697 versus 0.619, P < 0.001).
CONCLUSION: A CBC-based prognostic index was developed and had a higher prediction efficiency on 5 year DSS in NPC than the TNM system alone.
Copyright © 2013 The Royal College of Radiologists. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Complete blood count; development; disease-specific survival; nasopharyngeal carcinoma; prognostic index; validation

Mesh:

Substances:

Year:  2013        PMID: 23910226     DOI: 10.1016/j.clon.2013.07.004

Source DB:  PubMed          Journal:  Clin Oncol (R Coll Radiol)        ISSN: 0936-6555            Impact factor:   4.126


  25 in total

1.  Prognostic nomogram for refining the prognostication of the proposed 8th edition of the AJCC/UICC staging system for nasopharyngeal cancer in the era of intensity-modulated radiotherapy.

Authors:  Jian Ji Pan; Wai Tong Ng; Jing Feng Zong; Sarah W M Lee; Horace C W Choi; Lucy L K Chan; Shao Jun Lin; Qiao Juan Guo; Henry C K Sze; Yun Bin Chen; You Ping Xiao; Wai Kuen Kan; Brian O'Sullivan; Wei Xu; Quynh Thu Le; Christine M Glastonbury; A Dimitrios Colevas; Randal S Weber; William Lydiatt; Jatin P Shah; Anne W M Lee
Journal:  Cancer       Date:  2016-07-19       Impact factor: 6.860

2.  Risk factors and prediction-score model for distant metastasis in nasopharyngeal carcinoma treated with intensity-modulated radiotherapy.

Authors:  An-Chuan Li; Wei-Wei Xiao; Lin Wang; Guan-Zhu Shen; An-An Xu; Yan-Qing Cao; Shao-Min Huang; Cheng-Guang Lin; Fei Han; Xiao-Wu Deng; Chong Zhao
Journal:  Tumour Biol       Date:  2015-05-27

3.  Radiomics Analysis of PET and CT Components of PET/CT Imaging Integrated with Clinical Parameters: Application to Prognosis for Nasopharyngeal Carcinoma.

Authors:  Wenbing Lv; Qingyu Yuan; Quanshi Wang; Jianhua Ma; Qianjin Feng; Wufan Chen; Arman Rahmim; Lijun Lu
Journal:  Mol Imaging Biol       Date:  2019-10       Impact factor: 3.488

4.  Neutrophil-to-lymphocyte ratio as a prognostic factor for pharyngocutaneous fistula after total laryngectomy.

Authors:  F T Aires; R A Dedivitis; M A V Kulcsar; D M Ramos; C R Cernea
Journal:  Acta Otorhinolaryngol Ital       Date:  2018-02       Impact factor: 2.124

5.  A novel prognostic model predicts overall survival in patients with nasopharyngeal carcinoma based on clinical features and blood biomarkers.

Authors:  Changchun Lai; Chunning Zhang; Hualiang Lv; Hanqing Huang; Xia Ke; Chuchan Zhou; Hao Chen; Shulin Chen; Lei Zhou
Journal:  Cancer Med       Date:  2021-05-11       Impact factor: 4.452

6.  Leucopenia and treatment efficacy in advanced nasopharyngeal carcinoma.

Authors:  Zhen Su; Yan-Ping Mao; Pu-Yun OuYang; Jie Tang; Xiao-Wen Lan; Fang-Yun Xie
Journal:  BMC Cancer       Date:  2015-05-24       Impact factor: 4.430

7.  The neutrophil-lymphocyte ratio and its utilisation for the management of cancer patients in early clinical trials.

Authors:  R Kumar; E Geuna; V Michalarea; M Guardascione; U Naumann; D Lorente; S B Kaye; J S de Bono
Journal:  Br J Cancer       Date:  2015-03-31       Impact factor: 7.640

8.  Development and validation of a pretreatment prognostic index to predict death and lung metastases in extremity osteosarcoma.

Authors:  Bo Wang; Jian Tu; Junqiang Yin; Changye Zou; Jin Wang; Gang Huang; Xianbiao Xie; Jingnan Shen
Journal:  Oncotarget       Date:  2015-11-10

9.  Prognostic score models for survival of nasopharyngeal carcinoma patients treated with intensity-modulated radiotherapy and chemotherapy.

Authors:  Lei Zeng; Pi Guo; Jin-Gao Li; Fei Han; Qiang Li; Yong Lu; Xiao-Wu Deng; Qing-Ying Zhang; Tai-Xiang Lu
Journal:  Oncotarget       Date:  2015-11-17

10.  High Pretreatment Platelet-to-Albumin Ratio Predicts Poor Survival Results in Locally Advanced Nasopharyngeal Cancers Treated with Chemoradiotherapy.

Authors:  Veysel Haksoyler; Erkan Topkan
Journal:  Ther Clin Risk Manag       Date:  2021-07-05       Impact factor: 2.423

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.